Alternative to Meds Editorial Team
Medically Reviewed by Dr John Motl MD
Table of Contents:
Mood stabilizers that are given during a crisis often devolve into a lifetime of being medicated and all of the side effects that go with it. Some people can safely reduce or stop a mood stabilizer with medical support, and others do best staying on it. Relapse risk is real, so talk to your prescriber before making any change.
Do Your Symptoms Require Depakote?
Reasons to Consider Depakote Tapering
Depakote tapering — a gradual, carefully managed reduction — is the safest way to stop taking this mood stabilizer, classed as an antiepileptic medication. Abruptly stopping Depakote is NOT recommended as it can result in seizures that do not stop and other serious withdrawal symptoms.2 More details on withdrawals can be found in the section called “Depakote Withdrawal Symptoms,” below.
Depakote is linked to major congenital deformities such as spina bifida, deformed heart, and limbs.5,34 The FDA label also warns that valproate can cause lower IQ scores and neurodevelopmental disorders in children exposed before birth.3 Children exposed to valproate before birth have a higher risk of autism.42 The UK medicines regulator (MHRA) says about 1 in 9 babies exposed in the womb has a birth defect, and about 3 or 4 children in every 10 may have problems with early development.38 The FDA label says Depakote must not be used to prevent migraines in pregnant women, or in women who could become pregnant and are not using effective contraception.3 If you could become pregnant, talk to your prescriber about contraception and other treatment options. If you are pregnant, contact your prescriber right away, but do not stop valproate suddenly on your own.38
Men are also given precautions. European and UK regulators advise men taking valproate to use effective contraception and to have their treatment reviewed by a specialist, because of a possible risk to children conceived while the father was taking valproate.38,39 Newer studies from 2026 have not confirmed that risk.40,41 Men who are planning a family should discuss this with their prescriber.
Continuing a prescription of Depakote may become impractical due to side effects including sedation, confusion, loss of coordination, and vision problems if their job involves driving a vehicle, flying a plane, or operating heavy machinery.1,3 Find more details in the section below called “Depakote Side Effects.”
Overall, a person can assess the risk-benefit ratio of staying on a drug or not, and we also recommend researching Depakote alternative therapies that may offer other forms of help for mood swings or migraines, or whatever the original symptoms were. The Alternative to Meds Center offers such an opportunity. The center offers an inpatient Depakote tapering program, using neurotoxin removal, orthomolecular and nutrition-based medicine, lab testing and diagnosing root causes for unwanted conditions, and a wealth of additional therapeutic activities that can be tailored to the individual’s needs. We hope the following information helps in your research.
Depakote Tapering Guidelines and Schedule
The conversation about Depakote tapering is from the perspective of it being a mood stabilizer. We are not suggesting that the same methods be administered to a person with a seizure disorder.
For persons with a seizure disorder, we cannot give viable guidance as your situation will need to be designed directly with your prescriber. And regardless of the reasons why Depakote was prescribed, the below is only given so as to share with your prescriber, and most definitely not to act on without support.
If an inpatient setting is not available, find a prescriber to work with who is familiar with tapering protocols for Depakote, and who is supportive of your desire to taper. An unsupported taper is likely to go off the rails.
Depakote Tapering Guidelines include:
Begin Depakote tapering only when in a stable condition. (See below for more information.)
- Write a safety plan with your prescriber and a trusted person before you begin the process. (How to set up a safety plan is described in more detail below.)
- Seek inpatient care or at the very least, find a prescriber who is familiar with tapering protocols and willing to help you. NICE advises reducing valproate gradually over at least 4 weeks to lower the risk of relapse, and watching for early signs of relapse.35
- Discuss other medications you may be taking with your prescriber so your tapering plan can accommodate the best sequence in multiple drug discontinuations in a safe way. Inform your prescriber of all drugs taken concurrently including aspirin, antidepressants, antibiotics, oral contraceptives, and any others due to potential drug interactions.3,19,27
- You can ask your prescriber for the lowest dose version of your Depakote to more easily configure reduced doses as your tapering progresses. The lowest dose tablet is the salmon pink 125 mg delayed-release tablet. Depakote tablets should be swallowed whole, so your prescriber can plan small steps with other forms, such as sprinkle capsules or valproic acid liquid.3,37
- The last cuts may be the most difficult. Work closely with your physician and go slowly.28,33
- Discuss with your prescriber the option (if needful) to get a bridge medication such as Gabapentin prescribed at points of particular difficulty during the taper.14
- Regular exercise is recommended for positive benefits on mental health.16
- Caffeine can worsen sleep and anxiety, so keep it low and steady during the taper.15
- Avoid marijuana or other recreational drug use18 and eliminate alcohol. Alcohol can have harmful interactions with Depakote and disrupt the taper process.19
- Diet can help keep blood sugar balanced. A protein-based breakfast and numerous small protein-based meals over the day are better than 1 or 2 heavy, high-carb meals that may cause blood sugar levels to spike and crash.13
- The percent of reduction and the duration between cuts will depend on factors such as the intensity of symptoms, and how long it takes for each level to settle out. How long a person took drugs such as Depakote can influence how long to expect the withdrawal to take.17
- Become acquainted with symptoms that could manifest during the withdrawal 33 and speak to your prescriber about any new symptoms so you are working together as a team. More information on Depakote withdrawals is given in the earlier section called “Depakote Withdrawal Symptoms.”
- For your own safety, let your prescriber know if you notice red flags such as not sleeping, not eating well, or compulsive or other behavioral changes in your routine. These may indicate that tapering may need to be slowed (or dosage temporarily raised).28,33
- Consider limiting reading material, internet usage, and media of all kinds that you find overstimulating. Quiet, calm activities may be more helpful, i.e., a pleasant walk, work that you find easy to do, hobbies that you find engaging and relaxing, yoga, mindfulness awareness training, forest bathing, and other enjoyable activities in a calming environment.28,29,30,31
- For more information please reference our antipsychotic alternatives page.
Alternative to Meds Does Not Provide Rapid Detox
There are, rarely, instances when rapid or abrupt discontinuation of a drug like Depakote is medically necessary to save the life of the patient. For example, anticonvulsant-induced movement disorders, and other potentially life-threatening reactions such as Stevens-Johnson syndrome are rare but are known adverse events associated with Depakote. These must be treated in a hospital setting such as an emergency ward or ICU where abrupt discontinuation is most safely achieved.4,28 Alternative to Meds cannot provide the emergency medical treatment that is needed for rapid withdrawal in such cases, and we are not in a position to give guidance regarding rapid Depakote withdrawal.
Begin Depakote tapering only when you are in a stable condition.
It is best to begin a Depakote taper when the person is reasonably tolerating the medication, sleeping well, eating regularly, doing regular exercise, is under competent medical oversight from a willing prescriber. The best candidate would have eliminated caffeine and other stimulants, alcohol use, marijuana, or other recreational drug use because these substances can interact with and interfere with the medication’s mechanisms of action. This can throw a wrench into any taper program. having a support circle is extremely beneficial for support from family, close friends, and sympathetic mentors. Also arranging one’s life in an organized fashion might include engaging in hobbies or light work to focus on. If you are not sleeping well, that should be taken care of with the help of your prescriber or using holistic means that work well for you beforehand.
Make a safety plan before you start.
Reducing Depakote can bring back sleep problems, agitation, or mood symptoms, and in some people mania. During those times it can be hard to judge whether to keep going with the taper. Before you begin, write a safety plan with your prescriber and one or two people you trust. List your early warning signs, the people and clinicians to call, what changes in the taper plan you agree to in advance, and when to seek urgent care. Some people also sign an advance agreement (sometimes called a “Ulysses contract”) so that their support person can remind them of the plan they chose while they were well.20 If you have thoughts of harming yourself, call or text 988, call 911, or go to the nearest emergency room.
Set up medical support before your Depakote taper.
There are holistic psychiatrists and other prescribers who can assist you with an outpatient-style taper. Certainly, we recommend inpatient care when possible, but we know it may not always be possible or practical for everyone. When you find your outpatient doctor, you are welcome to share our information with them if you like, and we hope it helps open the discussion.
Eliminate all forms of caffeine or other stimulants, and recreational drugs.
Stimulants, alcohol, and recreational drugs can disrupt sleep and mood and make a taper harder to manage. Alcohol can also interact with Depakote. Keep caffeine low and steady, and avoid alcohol and recreational drugs during the taper.15,18,19
Food choices to control blood sugar spikes.
Blood sugar spikes and crashes can disrupt tapering with a vengeance. Choose low-glycemic, protein-based foods and snacks to prevent unnecessary problems. Don’t let hunger disrupt your progress. Breakfast should be protein-based giving a good start to the day. Follow up with smaller protein-based meals that also incorporate your favorite vegetables throughout the day. Experiment with some rutabaga or cauliflower for “mashed potatoes” — delicious with butter! Avoid refined flours and sugars or find low-carb replacements. Snacks like non-starchy veggies, peanut butter, avocado, raspberries, blueberries, dill pickles, cheeses, delicious cold cuts, and other sugar-free foods can deliciously fill in the gaps as needed.13
Many Benefits of Exercise.
Exercise has been documented well for the benefits to physical and mental health. For example, Sharma et al’s comprehensive summary24 of benefits lists improved mood, energy, and better sleep that should be emphasized and encouraged by mental health professionals.
Aerobic exercise, such as brisk walking, swimming, or cycling, is an easy way to build these benefits into the day. Start gently and build up over time.16,24
Use the smallest milligram dose of Depakote available to use for the taper.
The smallest milligram dose of Depakote is the salmon pink 125 mg delayed-release tablet. This does not mean you want to drop to the lowest dose. Smaller strengths help your prescriber set each dose accurately. Your prescriber plans each dose step. The FDA labels say Depakote delayed-release and Depakote ER tablets should be swallowed whole and not crushed or chewed, so do not split them unless your prescriber or pharmacist tells you to.3,36 Depakote Sprinkle Capsules may be swallowed whole or opened onto soft food, and valproic acid also comes as a liquid; your prescriber may use these for small steps.37 Depakote ER and Depakote delayed-release are not interchangeable milligram for milligram. ER doses run 8 to 20% higher to give the same exposure, so any switch between them is a prescriber decision.36 These small steps are not necessary for everyone, but for some, a slow pace is the only path to re-regulation after the use of the drug. Keep a written record, and don’t rely on “mental math” in the middle of a Depakote taper.
Other medications you are on.
The CDC reported that between 2015 and 2018 about 24% of the US population took 3 or more medications over a 30-day period, and over 12% took 5 or more medications in the same period. It is not at all unlikely that a person who has been taking Depakote for some time may have also been prescribed other medications for various reasons. Tapering within an inpatient setting would be particularly advised in this case. The order or sequence of which medications to taper is vital so as not to overwhelm the body by introducing too much change all at once. These matters can be assessed and managed more easily in an inpatient setting, as both the micro-changes and the broader modifications can be made when needed on an immediate basis.21 In any case it would be advised to speak with your prescribing doctor who is helping with your taper and discuss the best sequence, depending on what medications were prescribed and for what reasons they were originally prescribed.
Factors that would have to be considered include how long a person was taking each drug, the symptoms the person was attempting to control, current symptoms, and other issues that are unique to each individual.
How long will Depakote tapering last?
Because each person has unique biomarkers, genetic profile, medical history, sensitivities, individualized sets of symptoms, and so on, there is no “one-size-fits-all” when it comes to Depakote tapering. Like maneuvering down a mountain road, sometimes shifting to a lower gear is more effective than slamming on the brakes too aggressively. Slow and safe are the keywords to keep in mind.
Some medications may take months, or even years to resolve as demonstrated in benzodiazepine clinical studies,22 as well as studies on discontinuation of mood stabilizers.23
However, we have observed that when effective tapering support is provided, these numbers typically decrease as the body is maximally assisted in the rehabilitation of its normal neurochemistry.
Red Flags of Depakote Tapering
Returning to our analogy of driving a logging truck down a mountain with switchbacks on an icy road, you have to go light on the accelerator — go slow — and be ready to use your brakes. If you are a patient, skillful driver, you will get safely down the mountain. Free-wheeling it will likely end in a crash — an avoidable disaster. Accelerating around the turns because it feels good can turn out like the wreck that you would anticipate in our driving scenario. We observe similar laws of gravity and inertia involved in Depakote tapering. Go slow so you can get down the mountain. That is the over-arching axiom.
Not eating, not sleeping, intense side effects, and perseverating (obsessing) over a certain topic that will not leave your mind are all red flags. These are signs you are heading into the danger zone. For instance, after the second day of not sleeping, that could be a signal to pay attention to. It may be that you need to go back up on your medications. Then you can work your way back to the earlier dose. Please talk to your prescriber about the likelihood of encountering these moments of crisis before you begin Depakote tapering so you have a better understanding of what to expect. Don’t try to figure it out mid-crisis. You don’t want to end up in the hospital back at square one. If you begin to feel you pose a danger to yourself or those around you, call or text 988, call 911, or go to the nearest emergency room. Getting checked in the hospital is the safe choice. Hospitalization is not a failure. It could be that being medication-free is not the best outcome. Or it could signal that a much longer withdrawal period is needed. Watch for red flags and respond to them by collaborating with your prescriber without delay.
Bridge medications for Depakote tapering.
Some persons may do well using what are referred to as bridge medications to ease Depakote withdrawal. At Alternative to Meds Center, various methods of tapering can safely ease withdrawal issues and bridge medications can be designed on an individual basis.
Limiting stimulating media during Depakote Tapering.
Wrestling with life questions, religious matters, and watching over-stimulating movies or TV, can all be overwhelming for someone attempting Depakote tapering. Better activities might include outside walking, physical activity, hobbies you enjoy, light reading, light work, or things that can pleasantly extrovert the attention. These types of activities can act as grounding elements that support your tapering process very well.
Depakote Alternatives and Depakote Withdrawal Links
We have pages on our site that address Depakote alternatives that can be used during the tapering process. We strongly recommend you review these pages. Quick links are Antipsychotic Alternatives for general information on nutrition, etc., and Depakote Alternatives. You may also want to consider reading the Depakote Withdrawal page.
Depakote Side Effects
The FDA drug label3 lists the following:
- Birth defects, lower IQ, and developmental disorders in children exposed before birth (boxed warning)
- Life-threatening pancreatitis (all ages)
- Coma, severe or fatal encephalopathy (loss of brain function)3,8
- Dementia
- Liver failure (fatal hepatotoxicity); higher risk in people with mitochondrial disorders such as POLG-related disease
- Seizures, tremors
- Suicidal thoughts and behavior as early as the 1st week of taking Depakote
- Decreased blood platelet levels
- Drowsiness, sedation, confusion, dizziness
- Stevens-Johnson syndrome, toxic skin necrolysis, temporary hair loss, rashes
- Nausea
- Constipation, diarrhea, abdominal cramps
- Headaches
- Sexual loss of interest
- Anxiety, nervousness
- Depression
- Mood swings, uncontrolled laughing or crying, often at inappropriate times
- Anorexia, weight gain, weight loss
- Bronchitis, fever, flu syndrome
- Bleeding under the skin resulting in purple patches
- Amnesia
- Blurred vision, double vision
- Abnormal thinking
- Insomnia
- Abnormal muscle weakness
- Accidental injury
Notes on Rebound Symptoms after Stopping Depakote Too Quickly.
For a person with epilepsy to abruptly stop or even reduce Depakote, one of the most concerning reactions is episodes of seizures that do not stop, also called status epilepticus.6 For bipolar persons, a sudden cessation of Depakote can bring on a return of the person’s original symptoms such as mania, insomnia, etc. A person who was taking Depakote as a treatment for migraines may have a return of migraines, which may be considerably more severe than before taking valproate. A person taking Depakote as a mood stabilizer, for bipolar, for headaches, or for other conditions may find that reducing the drug too quickly can cause intense reactions. Sometimes these withdrawal adverse effects can linger on if they are not addressed in a healthy way as part of the tapering process.7
Depakote Withdrawal Symptoms
Depakote withdrawals can include both rebound (returning) symptoms and new symptoms, including the following:
- Rebound seizures
- Seizures in non-epileptic persons 9
- Anxiety, agitation, irritability
- Depression
- Insomnia
- Headache
- Muscle aches, weakness
- Loss of coordination, loss of concentration, feeling faint
- Twitching
- Nausea, vomiting
- Tremors, shaking
- Perspiring excessively
- Photophobia (hyper-sensitive to light)
- Impaired memory
- Tachycardia (racing heart rate at rest)
- Anorexia
Slowly reducing the medication with other support mechanisms in place are the means used to offset these reactions.
WARNING: Never abruptly or quickly stop taking Depakote. Find help to assist you with the challenges of Depakote tapering or coming off any psychoactive substance.
What is Depakote?
Depakote is an anticonvulsant (antiseizure) drug, often used as a mood stabilizer in bipolar conditions, and used to control epileptic seizures and migraine headaches. The generic name is divalproex sodium or simply valproate or valproic acid. There is an extended-release version of the drug called Depakote ER (sustained-release), which is taken once a day and released slowly over a 24-hour period. There is also a “delayed-release” version called Depakote (enteric-coated delayed-release tablets) which is NOT time-release but has a protective enteric coating that dissolves only after it reaches the intestines, then releasing the medication all at once. The delayed-release (non-sustained release) version is usually taken in divided doses through the day. There is also a “sprinkles” version which is delayed-release (not 24-hr sustained-release) that was designed to be sprinkled on soft food for those who have trouble swallowing capsules.6
While this anticonvulsant drug is not a benzodiazepine, in their 2021 book entitled “Valproic Acid.” Rahman and Nguyen conclude that the mechanism of action is in some ways similar, and involves the control of GABA distribution (and other neurochemicals) along the CNS.10 GABA is a calming natural chemical, though the complex mechanism of action and its interactions with other transmitters and molecules and messaging systems are not entirely understood. Its calming properties make it useful in acute situations such as alcohol withdrawal, where controlling symptoms of alcohol withdrawal is desired without the use of benzodiazepines.11
Contact Alternative to Meds Center
You or your loved one may be struggling with side effects, tolerance, or other issues that may be blocking your ability to enjoy natural mental health and be truly well. You owe it to yourself to find out more about how the Alternative to Meds Depakote tapering program works, whether you feel you would be a good candidate, and how it could possibly assist you to overcome these challenges.
for Depakote Tapering Help
1. Veteran and Family Handout, “Facts About Mood Stabilizers” [cited 2022 July 21]
2. AppVie Drug Manufacturer website, “Depakote frequently asked questions.” [cited 2022 July 21]
3. DailyMed. Depakote (divalproex sodium) delayed-release tablets, prescribing information (AbbVie; revised 2026). [cited 2026 Nov 17]
4. HCP Live Tardive Dyskinesia Highly Prevalent with Certain Non-antipsychotic Medication July 17, 2017, Ellen Kurek [cited 2022 July 21]
5. Koren G, Nava-Ocampo AA, Moretti ME, Sussman R, Nulman I. Major malformations with valproic acid. Can Fam Physician. 2006;52(4):441-447. [cited 2022 July 21]
6. Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980 Nov;69(5):657-66. doi: 10.1016/0002-9343(80)90415-5. PMID: 7435509. [cited 2022 July 21]
7. Cosci F, Chouinard G: Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychother Psychosom 2020;89:283-306. doi: 10.1159/000506868 [cited 2022 July 21]
8. Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE. Different clinical manifestations of hyperammonemic encephalopathy. Epilepsy Behav. 2007 Jun;10(4):583-7. doi: 10.1016/j.yebeh.2007.02.013. Epub 2007 Apr 6. PMID: 17412645. [cited 2022 July 21]
9. Oto M, Espie C, Pelosi A, et al The safety of antiepileptic drug withdrawal in patients with non-epileptic seizures Journal of Neurology, Neurosurgery & Psychiatry 2005; 76:1682-1685. [cited 2022 July 21]
10. Rahman M, Nguyen H. Valproic Acid. [Updated 2021 Jan 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559112/ [cited 2022 July 21]
11. Reoux JP, Saxon AJ, Malte CA, Baer JS, Sloan KL. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial. Alcohol Clin Exp Res. 2001 Sep;25(9):1324-9. PMID: 11584152. [cited 2022 July 21]
12. Merk Manual, “Tolerance and Resistance to Drugs.” Lynch S, 2019 Aug [cited 2022 July 21]
13. Bansal N, Weinstock RS. Non-Diabetic Hypoglycemia. [Updated 2020 May 20]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK355894/ [cited 2022 July 21]
14. Zullino D, Miozzari A, Preisig M, “Gabapentin-Assisted Benzodiazepine Withdrawal in a Multidrug Dependant Patient.” Internet Journal of Pharmacology [cited 2022 July 21]
15. Broderick P, Benjamin AB. Caffeine and psychiatric symptoms: a review. J Okla State Med Assoc. 2004 Dec;97(12):538-42. PMID: 15732884. [cited 2022 July 21]
16. Deslandes A, Moraes H, Ferreira C, Veiga H, Silveira H, Mouta R, Pompeu FA, Coutinho ES, Laks J. Exercise and mental health: many reasons to move. Neuropsychobiology. 2009;59(4):191-8. doi: 10.1159/000223730. Epub 2009 Jun 10. PMID: 19521110. [cited 2022 July 21]
17. Lerner A, Klein M. Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development. Brain Commun. 2019;1(1):fcz025. Published 2019 Oct 16. doi:10.1093/braincomms/fcz025 [cited 2022 July 21]
18. NIDA. Is there a link between marijuana use and psychiatric disorders?. National Institute on Drug Abuse website. https://www.drugabuse.gov/publications/research-reports/marijuana/there-link-between-marijuana-use-psychiatric-disorders. May 28, 2020 [cited 2022 July 21]
19. NIH “Fact Sheet: Harmful Interactions.” [published online 2003, revised 2014] [cited 2022 July 21]
20. Volk ML, Lieber SR, Kim SY, Ubel PA, Schneider CE. Contracts with patients in clinical practice. Lancet. 2012;379(9810):7-9. doi:10.1016/S0140-6736(11)60170-0 [cited 2022 July 21]
21. CDC FastStats: Therapeutic Drug Use [published online 2019] [cited 2022 July 21]
22. Nardi AE, Freire RC, Valença AM, Amrein R, de Cerqueira AC, Lopes FL, Nascimento I, Mezzasalma MA, Veras AB, Sardinha A, de Carvalho MR, da Costa RT, Levitan MN, de-Melo-Neto VL, Soares-Filho GL, Versiani M. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment. J Clin Psychopharmacol. 2010 Jun;30(3):290-3. doi: 10.1097/JCP.0b013e3181dcb2f3. PMID: 20473065.[cited 2022 July 21]
23. Qureshi MM, Young AH. Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder. Ther Adv Psychopharmacol. 2021;11:20451253211000612. Published 2021 Mar 15. doi:10.1177/20451253211000612 [cited 2022 July 21]
24. Sharma A, Madaan V, Petty FD. Exercise for mental health. Prim Care Companion J Clin Psychiatry. 2006;8(2):106. doi:10.4088/pcc.v08n0208a [cited 2022 July 21]
25. Messerschmidt A, “Enzymes and Enzyme Mechanisms” excerpt from the book “Comprehensive Natural Products II” from Science Direct website [2010] [cited 2022 July 21]
26. Medical University of Vienna, (2016, August 31). Dopamine: Far more than just the ‘happy hormone’. ScienceDaily. [cited 2022 July 21]
27. List of 429 drugs that may interact with Depakote published on drugs .com [cited 2026 April 15]
28. Keks N, Schwartz D, Hope J. Stopping and switching antipsychotic drugs. Aust Prescr. 2019;42(5):152-157. doi:10.18773/austprescr.2019.052 [cited 2022 July 21]
29. Kuppili PP, Parmar A, Gupta A, Balhara YPS. Role of Yoga in Management of Substance-use Disorders: A Narrative Review. J Neurosci Rural Pract. 2018;9(1):117-122. doi:10.4103/jnrp.jnrp_243_17 [cited 2022 July 21]
30. Dakwar E, Mariani JP, Levin FR. Mindfulness impairments in individuals seeking treatment for substance use disorders. Am J Drug Alcohol Abuse. 2011;37(3):165-169. doi:10.3109/00952990.2011.553978 [cited 2022 July 21]
31. Kotera Y, Rhodes C. Commentary: Suggesting Shinrin-yoku (forest bathing) for treating addiction. Addict Behav. 2020 Dec;111:106556. doi: 10.1016/j.addbeh.2020.106556. Epub 2020 Jul 15. PMID: 32745943. [cited 2022 July 21]
32. Rahman M, Nguyen H. Valproic Acid. [Updated 2021 Oct 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559112/ [cited 2022 July 21]
33. Chouinard G, Samaha AN, Chouinard VA, Peretti CS, Kanahara N, Takase M, Iyo M. Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy. Psychother Psychosom. 2017;86(4):189-219. doi: 10.1159/000477313. Epub 2017 Jun 24. PMID: 28647739. [cited 2022 July 21]
34. Werler MM, Ahrens KA, Bosco JL, Mitchell AA, Anderka MT, Gilboa SM, Holmes LB; National Birth Defects Prevention Study. Use of antiepileptic medications in pregnancy in relation to risks of birth defects. Ann Epidemiol. 2011 Nov;21(11):842-50. doi: 10.1016/j.annepidem.2011.08.002. PMID: 21982488; PMCID: PMC4816042. [cited 2022 July 21]
35. National Institute for Health and Care Excellence. Bipolar disorder: assessment and management (CG185), recommendations 1.7.11-1.7.12 and 1.10.35. [cited 2026 Nov 17]
36. DailyMed. Depakote ER (divalproex sodium) extended-release tablets, prescribing information (AbbVie; revised 2026). [cited 2026 Nov 17]
37. DailyMed. Depakote Sprinkle Capsules (divalproex sodium), prescribing information (AbbVie; revised 2026). [cited 2026 Nov 17]
38. Medicines and Healthcare products Regulatory Agency. Valproate: reproductive risks. Published 10 June 2025, updated 23 September 2025. [cited 2026 Nov 17]
39. European Medicines Agency. Potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines: PRAC recommends precautionary measures. 12 January 2024. [cited 2026 Nov 17]
40. Meng LC, van Gelder MMHJ, Chuang HM, et al. Valproate Use by Fathers and Risk of Neurodevelopmental Disorders in Children. NEJM Evid. 2026 Mar;5(3):EVIDoa2500254. doi: 10.1056/EVIDoa2500254. PMID: 41733407. [cited 2026 Nov 17]
41. Christensen J, Trabjerg BB, van Gelder MMHJ, et al. Risk of neurodevelopmental disorders associated with paternal use of valproate during spermatogenesis: a living meta-analysis-version 1. J Neurol Neurosurg Psychiatry. 2026 Sep 14;97(10):890-898. doi: 10.1136/jnnp-2026-338454. PMID: 42120066. [cited 2026 Nov 17]
42. Christensen J, Grønborg TK, Sørensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA. 2013 Apr 24;309(16):1696-703. doi: 10.1001/jama.2013.2270. PMID: 23613074. [cited 2026 Nov 17]
Originally Published Dec 14, 2019 by Diane Ridaeus
Dr. John Motl, M.D.
Dr. Motl is currently certified by the American Board of Psychiatry and Neurology in Psychiatry, and Board eligible in Neurology and licensed in the state of Arizona. He holds a Bachelor of Science degree with a major in biology and minors in chemistry and philosophy. He graduated from Creighton University School of Medicine with a Doctor of Medicine. Dr. Motl has studied Medical Acupuncture at the Colorado School of Traditional Chinese Medicine and at U.C.L.A.
Social Profile: LinkedIn
Diane is an avid supporter and researcher of natural mental health strategies. Diane received her medical writing and science communication certification through Stanford University and has published over 3 million words on the topics of holistic health, addiction, recovery, and alternative medicine. She has proudly worked with the Alternative to Meds Center since its inception and is grateful for the opportunity to help the founding members develop this world-class center that has helped so many thousands regain natural mental health.